The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
Abstract Over the past 22 years, annual GOLD Reports have documented important changes in guidance and recommendations for uniformly treating patients with chronic obstructive pulmonary disease (COPD) with the goal of improving outcomes in patients suffering from this condition. The most recent GOLD...
Main Authors: | Paul D. Terry, Rajiv Dhand |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-07-01
|
Series: | Pulmonary Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s41030-023-00233-z |
Similar Items
-
Choosing the right inhaler for your asthma or COPD patient
by: Usmani OS
Published: (2019-03-01) -
The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01) -
Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
by: Veronika Mangold, et al.
Published: (2023-10-01) -
Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
by: Peng Y, et al.
Published: (2021-09-01) -
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
by: Lutter JI, et al.
Published: (2021-04-01)